about
Analysis of plasma cytokines and angiogenic factors in patients with pretreated urothelial cancer receiving Pazopanib: the role of circulating interleukin-8 to enhance the prognostic accuracyResponse to imatinib plus sirolimus in advanced chordoma.Phase II study on lapatinib in advanced EGFR-positive chordoma.Imatinib in advanced chordoma: A retrospective case series analysis.Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response.High-dose continuous-infusion ifosfamide in advanced well-differentiated/dedifferentiated liposarcomaResponse to sunitinib malate in advanced alveolar soft part sarcoma.Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series.Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case reportResponse of conventional chondrosarcoma to gemcitabine alone: a case reportExtraskeletal myxoid chondrosarcoma: tumor response to sunitinib.Pulmonary nodules: volume repeatability at multidetector CT lung cancer screening.Gastrointestinal stromal tumors: evolving role of the multidisciplinary team approach in management.Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial.Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.Bevacizumab-based neoadjuvant chemotherapy for colorectal cancer liver metastases: Pitfalls and helpful tricks in a review for clinicians.Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.Sirolimus in Advanced Epithelioid Hemangioendothelioma: A Retrospective Case-Series Analysis from the Italian Rare Cancer Network Database.Solitary fibrous tumour presenting with a single bone metastasis: report of six cases and literature review.Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm.Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis.The symptom interval in children and adolescents with soft tissue sarcomas.Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour.A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact.Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma.Correlation between radiological assessment and histopathological diagnosis in retroperitoneal tumors: analysis of 291 consecutive patients at a tertiary reference sarcoma center.Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile.Tumor response to sunitinib malate observed in clear-cell sarcoma.Intrahepatic flow redistribution in patients treated with radioembolization.[Gastrointestinal interventional radiology. Technics and preliminary results].Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics.Loss of heterozygosity analysis at different chromosome regions in Wilms tumor confirms 1p allelic loss as a marker of worse prognosis: a study from the Italian Association of Pediatric Hematology and Oncology.Efficacy of topotecan plus vincristine and doxorubicin in children with recurrent/refractory rhabdomyosarcoma.CT-guided percutaneous cryoablation of renal masses in selected patients.Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial.Preclinical and clinical evidence of activity of pazopanib in solitary fibrous tumour.High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.Evaluation of response after pre-operative radiotherapy in soft tissue sarcomas; the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) and Imaging Group recommendations for radiological examiUse of a retrievable vena cava filter with low-intensity anticoagulation for prevention of pulmonary embolism in patients with cancer: an observational study in 106 cases.
P50
Q30563774-5E49C30F-954C-4533-9086-58B96458510EQ33273440-A1A304FE-0F69-497A-BB24-077FC3959D85Q33274760-E1228999-CE94-42C9-8AD3-3C8E266DB275Q33275725-8719FAF4-3747-4B4F-A386-49E8F9EDCEF9Q33276384-88E67212-A90C-4ACA-9FE7-CC36EF608093Q33389496-5BAFD4DB-D074-4DEE-8D07-69670DD28B35Q33420031-1FD3BF85-4A20-41A4-95A2-A3B30B1F541CQ34603983-5FC2DD77-6D70-4FDB-9466-DBC2F57491C4Q34608105-BAC09880-DB19-4852-95A2-79A197B11836Q34669336-9CA32C9A-F830-4FD7-8C0C-8D0CE0B18DF4Q35194125-944A7ACE-1C36-4AB4-A19B-CF1173C7BC2DQ36499849-B40EBC8A-1F96-4A96-9CC1-E76FD3C8F8F6Q37452513-FE39A8A4-8BD1-476C-AB18-D83271A51F39Q38009854-73675B68-4B7A-43C0-AFCF-63EAAA1331CCQ38028124-33697A16-9F8E-4253-8F2F-439B2DB5C6DDQ38386665-5604E905-1775-45B3-A9C2-6909E5DAB771Q38469579-9B25C9BC-32E5-4C5E-BEEA-B4379B97FE75Q38538075-73C0FFB6-95EC-4975-AA20-D1CE3EEC6BFAQ38873696-300C0987-A066-4F78-AA3D-3982264D7A49Q38944688-F594E56D-0414-44B6-B2C3-D462A88B7EE7Q39068978-3CDFC6E0-4A21-4440-86DE-ABDCD501B108Q39180339-CC4E9962-08B0-49AD-BA53-A517A6C97B1BQ39934939-2B7D004E-BDF5-4D6A-B9D5-5F46769299CAQ40296990-299EF171-D56C-44C3-8796-BF26B8E078B8Q40485928-639C40C8-05A7-464C-814D-A9572F10BB6EQ40582565-C7F50F48-B303-4CF5-BCE3-19BF10166BF3Q41749275-EA759379-0B6C-48C6-87AE-6DC71CCD9DD3Q42216297-35207B67-E343-49D2-B517-126901BB2089Q43186637-5836C426-CF28-48B1-B164-10205A487A85Q44546861-E3961093-8DFC-47CC-A1BA-A79D546E2087Q44958480-BDE69570-E392-4F64-BBE0-3256290BA999Q45345506-6F7DF1CC-A4F6-4FC7-B980-C62500337696Q45760446-CAF1E7D8-3F59-4F3B-8FD1-B0191A45FAEBQ46446193-D7C5CE5C-F456-487E-9852-BB6F5C583658Q48220175-8411BD0F-0685-4781-B504-E125E063B60FQ51181963-971E5D98-43CA-4FA9-BCCB-5FAB252437BCQ51694181-10909D73-EBBA-4324-9E28-602FE355792EQ51849514-E0B569CF-2CEA-4EDF-BB66-86F8E5B56729Q52818451-3CC11DEE-281D-4017-A429-15429D2ECC9DQ53151543-C57F3300-6F7B-4873-A53B-55E830786D69
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carlo Morosi
@ast
Carlo Morosi
@en
Carlo Morosi
@es
Carlo Morosi
@nl
Carlo Morosi
@sl
type
label
Carlo Morosi
@ast
Carlo Morosi
@en
Carlo Morosi
@es
Carlo Morosi
@nl
Carlo Morosi
@sl
prefLabel
Carlo Morosi
@ast
Carlo Morosi
@en
Carlo Morosi
@es
Carlo Morosi
@nl
Carlo Morosi
@sl
P1053
F-6824-2017
P106
P1153
36785825400
P21
P31
P3829
P496
0000-0003-4940-2185